Correction to: Leukemia (2013) 27, this issue; doi:10.1038/leu.2013.224
Since the publication of this article, the authors have identified an error contained in Figure 6 (panel c).
OS of DLBCL cases (n=233) according to HIP1R, FOXP1 or combined HIP1R/FOXP1 transcript levels. Data were reanalyzed from the Lenz et al.6 data set (Gene Expression Omnibus accession no. GSE10846). Kaplan–Meier curves in (a) and (b) were grouped on the basis of the lower quartile Q1 of HIP1R or higher-than-median FOXP1 transcript values, and both cohorts showed significantly worse outcome, P=0.0044 and P=0.0113, respectively. (c) The FOXP1hi/HIP1Rlo subgroup (FOXP1⩾median/HIP1R⩽Q1) showed a significantly inferior outcome (P=0.0004).
FOXP1hi/HIP1Rlo has been incorrectly listed as FOXP1hi/HIP1Rhi.
The correct figure appears below.
The error has now been rectified, and the correct article appears in this issue. The html and online pdf versions have also been rectified, and now carry the correct paper.
The Publisher would like to apologize for any inconvenience this may have caused.
Accession codes
Accession codes
Additional information
The online version of the original article can be found at 10.1038/leu.2013.224
Rights and permissions
About this article
Cite this article
Wong, K., Gascoyne, D., Brown, P. et al. Erratum: Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients. Leukemia 28, 470 (2014). https://doi.org/10.1038/leu.2013.276
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.276
